# US 2015/0098899 A1 · Particulate Materials And Compositions For Radio Therapy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0098899 A1
- Document ID: US20150098899A1
- Status: Published application
- Kind: A1
- Application number: 14/223,136
- Filed: 2014-03-24
- Published: 2015-04-09
- Earliest claimed: 2004-03-05
- Assignees: XL Sci-Tech, Inc.
- Inventors: Yongren Benjamin PENG; Xingye Cherry Lei
- Web page: https://patentgrep.com/patent/US20150098899A1

## CPC

- A61K 51/1217: {Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols}
- A61N 5/1027: {Interstitial radiation therapy}
- A61K 51/1251: {micro- or nanospheres, micro- or nanobeads, micro- or nanocapsules}
- A61K 51/1255: {Granulates, agglomerates, microspheres}
- A61L 27/425: {of phosphorus containing material, e.g. apatite}
- A61L 27/427: {of other specific inorganic materials not covered by A61L27/422 or A61L27/425}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 27/58: Materials at least partially resorbable by the body
- A61P 35/00: Antineoplastic agents
- A61L 2300/44: Radioisotopes, radionuclides
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Timed-bioresorbable particulates, particularly microspheres or fibers, may be used as a vehicle for delivery of radioisotopes, such as Y-90 and Pd-103 for localized radiotherapy, or as an embolic device. These particulates may also be embedded in polymers, or dispersed in injectable gels or other injectable media for the treatment of various cancers. The benefit of bioresorption, the ability to control the ratio of radioisotopes in the particulate, especially the gamma and beta ratios such as In-111/Y-90 ratio in a particulate, and the benefit of non-conductive implants are disclosed.

## Claims

### Claim at position 1

1-35. (canceled)

### Claim 36

A suspension comprising a matrix suspended or dispersed in viscous medium, tissue adhesive medium, iodized medium, or gel medium, wherein said matrix comprises radioactive isotopes.

### Claim 37 (depends on 36)

The suspension of claim 36, wherein said radioactive isotopes are Y-90, In-111, Pd-103, P-32, Cs-131, Sm-153, Ho-166, Tc-99m, Yb-169, Au-198, Re-188, Re-186, Ir-192, Lu-177, Ba-140, Se-72, 1-131, 1-125, Sr-90, Dy-165, Er, Tl, Sr, Gd, Y-90/In-111, Y-90/Tc-99m, P-32/In-111, P-32/Tc-99m, Ho-166/In-111, Ho-166/Tc-99m, Sm-153/In-111, Sm-153/Tc-99m, or combinations thereof.

### Claim 38 (depends on 36)

The suspension of claim 36, wherein said radioactive isotopes are present in an amount effective for radiation therapy of a tumor.

### Claim 39 (depends on 36)

The suspension of claim 36, wherein said matrix is a particulate, microsphere, porous microsphere, hollow microsphere, microcapsule, solid or porous fiber, small solid or porous rod, particulate dispersed in biopolymers, particulate dispersed in bioresorbable sutures, particulate dispersed in biocompatible gels, particulate dispersed in other media, or combinations thereof.

### Claim 40 (depends on 36)

The suspension of claim 36, wherein said viscous medium is pyrogen-free 85% glycerol.

### Claim 41 (depends on 36)

The suspension of claim 36, wherein said iodized medium is iodized lipiodol.

### Claim 42 (depends on 36)

The suspension of claim 36, wherein said matrix is a microsphere that comprises Yttrium-90.

### Claim 43 (depends on 42)

The suspension of claim 42, wherein said microsphere is solid, porous, or hollow.

### Claim 44 (depends on 36)

The suspension of claim 36, wherein said matrix comprises oxides, oxides containing nitrogen, nitrides, or combinations thereof.

### Claim 45

A resorbable implant material comprising: (i) a resorbable base oxide matrix which is biocompatible; and (ii) a nitrogen-rich surface layer formed on the resorbable base oxide matrix, the surface layer being of greater durability than the base oxide matrix.

### Claim 46 (depends on 45)

The implant material of claim 45, wherein the nitrogen-rich layer comprises about 15% molar nitrogen.

### Claim 47 (depends on 45)

The implant material of claim 45, wherein the base oxide matrix is oxide fibers, oxide microspheres or oxide particulates.

### Claim 48 (depends on 45)

The implant material of claim 45, wherein durability of the implant material is controlled by base oxide composition, nitrogen content or combination thereof.

### Claim 49 (depends on 45)

The implant material of claim 45, wherein the base oxide matrix is phosphate and borate or phosphate and silicate, wherein P2O5+B2O3 and P2O5+SiO2 content is in the range of 30% to 95%.

### Claim 50 (depends on 45)

The implant material of claim 45, wherein said implant material is embedded in a non-conductive delivery vehicle.

### Claim 51 (depends on 50)

The implant material of claim 50, wherein said non-conductive delivery vehicle is a biopolymer, bioresorbable suture, injectable gel, tissue adhesive, other media, or combinations thereof.

### Claim 52 (depends on 47)

The implant material of claim 47, wherein said oxide fibers, oxide microspheres or oxide particulates are embedded in poly-l-lactic acid in the molecular weight range of 30,000 to 500,000, poly-l-lactic acid co-polymers with polyglycolic acid, polydioanone (PDS II), polyglycaprone 25 (Moncryl), polyglactin 910 (Vicryl), phenyletheretherketone (PEEK), polysulfone (PSU), polyurethane, polypropylene, silicone, polyethylene terephthalate (PET), polyphenylene oxide blends (PPO), polyphenylsulfone (PPSU), polyether sulfone (PES), polyphenylene sulfide (PPS), polyetherimide (PEI), liquid crystal polymer (LCP), or combinations thereof.

### Claim 53 (depends on 36)

A method of radiotherapy comprising administering the suspension of claim 36 to an individual.

### Claim 54 (depends on 45)

A method of making the resorbable implant material of claim 45 comprising treating said resorbable base oxide matrix in ammonia.

### Claim 55 (depends on 47)

The implant material of claim 47, wherein said oxide fibers, oxide microspheres or oxide particulates are solid, porous, or hollow.
